Literature DB >> 6511706

The sensitivity of Giardia intestinalis to drugs in vitro.

P F Boreham, R E Phillips, R W Shepherd.   

Abstract

Techniques are described for the isolation, microculture and assessment of viability of Giardia intestinalis. The susceptibility of five recent Brisbane isolates and the Portland 1 stock to metronidazole, tinidazole, furazolidone and quinacrine has been determined. All stocks showed little variation in sensitivity to these drugs. The 3H-thymidine incorporation assay proved to be a much more sensitive method of assessing relative drug activity than either motility or dye exclusion methods. Tinidazole proved to be the most effective drug in vitro followed by furazolidone and metronidazole. Quinacrine was the least effective. The generation time of stocks in vitro varied from 12.5 to 44.2 h and the possible significance of this to failures in treatment is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6511706     DOI: 10.1093/jac/14.5.449

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  19 in total

1.  A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro.

Authors:  Linda A Dunn; Anita G Burgess; Kenia G Krauer; Lars Eckmann; Patrice Vanelle; Maxime D Crozet; Frances D Gillin; Peter Upcroft; Jacqueline A Upcroft
Journal:  Int J Antimicrob Agents       Date:  2010-04-24       Impact factor: 5.283

2.  Drug susceptibility testing of anaerobic protozoa.

Authors:  J A Upcroft; P Upcroft
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model.

Authors:  Gabriela Jenikova; Petr Hruz; Mattias K Andersson; Noa Tejman-Yarden; Patricia C D Ferreira; Yolanda S Andersen; Barbara J Davids; Frances D Gillin; Staffan G Svärd; Roy Curtiss; Lars Eckmann
Journal:  Vaccine       Date:  2011-10-12       Impact factor: 3.641

4.  A simple colourimetric method to determine anti-giardial activity of drugs.

Authors:  Haendel G N O Busatti; Maria A Gomes
Journal:  Parasitol Res       Date:  2007-03-28       Impact factor: 2.289

5.  Development of metronidazole-resistant lines of Blastocystis sp.

Authors:  L A Dunn; K S W Tan; P Vanelle; T Juspin; M D Crozet; T Terme; P Upcroft; J A Upcroft
Journal:  Parasitol Res       Date:  2012-02-24       Impact factor: 2.289

6.  Orally administered Giardia duodenalis extracts enhance an antigen-specific antibody response.

Authors:  L A Dunn; J A Upcroft; E V Fowler; B S Matthews; P Upcroft
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition.

Authors:  C A Bell; C C Dykstra; N A Naiman; M Cory; T A Fairley; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  Phenotypic and genotypic variation in Giardia lamblia isolates during chronic infection.

Authors:  P D Butcher; A M Cevallos; S Carnaby; E M Alstead; E T Swarbrick; M J Farthing
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity.

Authors:  C A Bell; M Cory; T A Fairley; J E Hall; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

10.  The old and new therapeutic approaches to the treatment of giardiasis: where are we?

Authors:  Haendel G N O Busatti; Joseph F G Santos; Maria A Gomes
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.